Google launched the Fitbit Edge on Monday. It costs $179.99, pre-orders are open, it ships on October 27, and it works with iPhones as well as Android phones.
The hardware is the cheap part. The two features your members are most likely to walk in and ask about, blood pressure trends and insulin resistance trends, do not come with the device. They need a Google Health Premium subscription, reported at $9.99 a month, on top of the $179.99.
What Google actually shipped
The Edge is the first Fitbit tracker with a screen since the Charge 6 in 2023. It carries a 1.34-inch display, its own GPS chipset, an altimeter, a skin temperature sensor carried over from the Pixel Watch, and electrical sensors that drive the ECG app. The battery is user-replaceable, a first for any Fitbit, and runs about a week with the always-on display off.
Google sits it between the screenless Fitbit Air at $99.99 and the Pixel Watch 5 at $349.99. Gemini-powered activity detection now recognises up to 100 workout types without the member starting anything. There is no NFC, so no tap-to-pay, which Charge 6 owners will notice. Full detail is in Google's announcement coverage.
So is it measuring blood sugar?
No. The insulin resistance feature never touches glucose. It infers a trend from signals the wrist already gives up: resting heart rate, sleep, skin temperature and activity, read over several weeks. Google's own documentation says it is not a prescreener for diabetes and tells users not to rely on it to manage the condition or change medication. It is a pattern with a medical-sounding name attached, sold as a subscription feature.
That matters because the thing it is not is the thing people will assume it is. A CGM (continuous glucose monitor) takes an actual reading from interstitial fluid and is a regulated medical device. This is an inference from a wristband. The feature was announced in August as part of Google's Health Guardian set, and Google says the underlying model was trained on more than a trillion minutes of data from five million opted-in users. A large training set makes a pattern more reliable. It does not turn it into a diagnosis.
What comes free and what does not
| Capability | Included with the $179.99 device | Needs Google Health Premium |
|---|---|---|
| Automatic workout detection, up to 100 types | Yes | |
| Heart rate, ECG app, SpO2 | Yes | |
| Built-in GPS and elevation | Yes | |
| Insulin resistance trends, no blood draw | Yes | |
| Blood pressure trends, no manual calibration | Yes |
Read the right-hand column as Google's actual business. The tracker is a one-off sale at a thin margin in a category investors have already started pricing more carefully. The subscription is recurring revenue, and the features that justify it are the ones that sound like health care.
What this means for your front desk
Some time after October 27, a member is going to arrive holding a phone and say their tracker flagged insulin resistance. Your staff will have about four seconds to respond, and there are two ways to get it wrong.
Wave it away and the member hears that you are not interested in the thing they are worried about. Engage too far and a trainer with a certification is now discussing a metabolic condition, which is not a conversation they are licensed to have. Neither is a judgement call you want made differently by whoever happens to be on the desk.
The fix is a single agreed line, written down, that every member of staff can say. Something close to: that trend is a pattern, not a test, and the people who can actually test it are your doctor, so take it to them. Then the part that is yours: resistance training and consistency are what we can help with, and they are what moves that pattern anyway.
This is the second time in a month a consumer platform has handed your members a piece of your intake. In October Apple shipped movement assessments that write the member an exercise plan, and we argued then that your trainer's first job is now responding to a plan they did not write. Apple gave that away. Google is charging $9.99 a month for its version.
Google priced the device at $179.99 and the interpretation at $9.99 a month. The interpretation is the product.